Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 8, 2007Hypertension

Novel Mechanisms of Valsartan on the Treatment of Acute Myocardial Infarction Through Inhibition of the Antiadhesion Molecule Periostin

View Full Paper
Ask AI
Bookmark
Share

Authors

KIKazuma IekushiNovartis (Japan)YTYoshiaki TaniyamaThe University of OsakaJAJunya AzumaMorinomiya University of Medical Sciences

Discussion

Loading...

Member takes

Overview

Does not support changing post-MI valsartan use; leaves open periostin as a remodeling target for future therapies.

Key Points

  • To investigate the molecular mechanisms regulating periostin expression in cardiac cells exposed to angiotensin II and mechanical stretch, and to assess whether valsartan attenuates periostin-mediated remodeling after myocardial infarction.
  • Assessed periostin expression in cultured cardiac myocytes and fibroblasts treated with angiotensin II, kinase pathway inhibitors, mechanical stretch, valsartan, and neutralizing antibodies.
  • Evaluated in vivo myocardial periostin levels and cardiac function at 4 weeks post-myocardial infarction with and without valsartan therapy.
  • Angiotensin II significantly upregulated periostin in myocytes and fibroblasts via PI3K, JNK, p38, and ERK1/2 pathways (P<0.05).
  • Mechanical stretch significantly elevated periostin expression (P<0.05), which was partially inhibited by valsartan and nearly completely abolished by valsartan combined with TGF-β and PDGF-BB neutralizing antibodies (P<0.05).
  • Periostin expression rose significantly in infarcted myocardium (P<0.05), whereas 4-week valsartan treatment significantly attenuated periostin upregulation and improved cardiac dysfunction (P<0.05).

Cite This Study

Iekushi et al. (2007) studied this question.

synapsesocial.com/papers/6a74155c55a91aadd1391b2chttps://doi.org/10.1161/hypertensionaha.106.080994
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Periostin as a Novel Factor Responsible for Ventricular Dilation2004 · 140 citations
  2. 2Changes in Ventricular Size and Function in Patients Treated With Valsartan, Captopril, or Both After Myocardial Infarction2005 · 295 citations
  3. 3Potential Contribution of a Novel Antifibrotic Factor, Hepatocyte Growth Factor, to Prevention of Myocardial Fibrosis by Angiotensin II Blockade in Cardiomyopathic Hamsters2000 · 175 citations
  4. 4Effects of Pressure Overload on Extracellular Matrix Expression in the Heart of the Atrial Natriuretic Peptide–Null Mouse2003 · 161 citations
  5. 5Mortality and Morbidity Remain High Despite Captopril and/or Valsartan Therapy in Elderly Patients With Left Ventricular Systolic Dysfunction, Heart Failure, or Both After Acute Myocardial Infarction2005 · 102 citations